Pitfalls, Problems, and Dilemmas in Applying the FIGO 2023 Staging System for Endometrial Cancer.

Q1 Medicine

Surgical Pathology Clinics Pub Date : 2026-12-01 Epub Date: 2026-08-26 DOI:10.1016/j.path.2026.06.007

Amy S Joehlin, Stephanie M McGregor

引用次数: 0

Abstract

The publication of FIGO 2023 staging for endometrial carcinoma (EC) fundamentally changed pathologic staging of EC by incorporating histologic subtypes, extent of lymphovascular space invasion, and molecular classification. In this article, the authors discuss the new staging system, the dilemmas with molecular classification, and clinical application details of histologic examination as they relate to the staging practices of surgical pathologists.

查看原文本刊更多论文

FIGO 2023分期系统应用于子宫内膜癌的陷阱、问题和困境

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Surgical Pathology Clinics Medicine-Surgery

CiteScore

4.40

自引率

0.00%

发文量

期刊介绍： This newest addition to the Clinics Series keeps you current on the information that is essential to every practicing surgical pathologist, from the latest techniques and approaches to detailed discussions on differential diagnosis. It devotes each and every issue exclusively to surgical pathology and its associated problems and is enhanced by abundant full-color images. Each issue focuses on a single topic-and is overseen by Guest Editors who are experts in their field-providing information of practical value on service while also offering material that increases understanding.